Get startedLog in
    Picture of United Laboratories International Holdings logo

    3933 — United Laboratories International Holdings Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for United Laboratories International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    C2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line8821,2032,0073,3443,289
    Depreciation
    Amortisation
    Non-Cash Items29721558.7-38.6-162
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-226-495-587-1,432-543
    Change in Accounts Receivable
    Change in Inventories
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities1,5681,5432,0312,4393,199
    Capital Expenditures-531-482-818-1,411-1,870
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items698-105224-146142
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities167-587-595-1,557-1,728
    Financing Cash Flow Items-123-41.3-33.7-42.314.7
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1,908-621-24.2-1,363597
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-1683341,412-4812,068